Your browser doesn't support javascript.
loading
Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.
Li, Wei; Li, Yunzhan; Liu, Zehua; Kerdsakundee, Nattha; Zhang, Ming; Zhang, Feng; Liu, Xueyan; Bauleth-Ramos, Tomás; Lian, Wenhua; Mäkilä, Ermei; Kemell, Marianna; Ding, Yaping; Sarmento, Bruno; Wiwattanapatapee, Ruedeekorn; Salonen, Jarno; Zhang, Hongbo; Hirvonen, Jouni T; Liu, Dongfei; Deng, Xianming; Santos, Hélder A.
Afiliação
  • Li W; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Li Y; State Key Laboratory of Cellular Stress Biology & Innovation Center for Cell Signaling Network and State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products and School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China.
  • Liu Z; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Kerdsakundee N; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, 90110 Hat Yai, Thailand.
  • Zhang M; State Key Laboratory of Cellular Stress Biology & Innovation Center for Cell Signaling Network and State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products and School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China.
  • Zhang F; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Liu X; State Key Laboratory of Cellular Stress Biology & Innovation Center for Cell Signaling Network and State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products and School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China.
  • Bauleth-Ramos T; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Instituto de Investigação e Inovação em Saúde (I3S), Instituto de Engenharia Biomédica (INEB), University of Porto, Rua Alfredo Allen, 208, 4200-135 Porto
  • Lian W; State Key Laboratory of Cellular Stress Biology & Innovation Center for Cell Signaling Network and State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products and School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China.
  • Mäkilä E; Laboratory of Industrial Physics, Department of Physics, University of Turku, Turku 20014, Finland.
  • Kemell M; Department of Chemistry, Faculty of Science, University of Helsinki, FI-00014, Helsinki, Finland.
  • Ding Y; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Sarmento B; Instituto de Investigação e Inovação em Saúde (I3S), Instituto de Engenharia Biomédica (INEB), University of Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal; Instituto Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo 228, 4150-180 Porto, Portugal.
  • Wiwattanapatapee R; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, 90110 Hat Yai, Thailand.
  • Salonen J; Laboratory of Industrial Physics, Department of Physics, University of Turku, Turku 20014, Finland.
  • Zhang H; Department of Pharmaceutical Sciences Laboratory & Turku Center for Biotechnology, Åbo Akademi University, Turku 20520, Finland.
  • Hirvonen JT; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Liu D; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland. Electronic address: dongfei.liu@helsinki.fi.
  • Deng X; State Key Laboratory of Cellular Stress Biology & Innovation Center for Cell Signaling Network and State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products and School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China. Electronic address: xmdeng@xmu.edu.
  • Santos HA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland. Electronic address: helder.santos@helsinki.fi.
Biomaterials ; 185: 322-332, 2018 12.
Article em En | MEDLINE | ID: mdl-30267958
ABSTRACT
Orally administrable drug delivery vehicles are developed to manage incurable inflammatory bowel disease (IBD), however, their therapeutic outcomes are compromised by the side effects of systemic drug exposure. Herein, we use hyaluronic acid functionalized porous silicon nanoparticle to bridge enzyme-responsive hydrogel and pH-responsive polymer, generating a hierarchical structured (nano-in-nano-in-micro) vehicle with programmed properties to fully and sequentially overcome the multiple obstacles for efficiently delivering drugs locally to inflamed sites of intestine. After oral administration, the pH-responsive matrix protects the embedded hybrid nanoparticles containing drug loaded hydrogels against the spatially variable physiological environments of the gastrointestinal tract until they reach the inflamed sites of intestine, preventing premature drug release. The negatively charged hybrid nanoparticles selectively target the inflamed sites of intestine, and gradually release drug in response to the microenvironment of inflamed intestine. Overall, the developed hierarchical structured and programmed vehicles load, protect, transport and release drugs locally to inflamed sites of intestine, contributing to superior therapeutic outcomes. Such strategy could also inspire the development of numerous hierarchical structured vehicles by other porous nanoparticles and stimuli-responsive materials for the local delivery of various drugs to treat plenty of inflammatory gastrointestinal diseases, including IBD, gastrointestinal cancers and viral infections.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Silício / Doenças Inflamatórias Intestinais / Budesonida / Preparações de Ação Retardada / Intestinos / Anti-Inflamatórios Limite: Animals / Humans / Male Idioma: En Revista: Biomaterials Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Silício / Doenças Inflamatórias Intestinais / Budesonida / Preparações de Ação Retardada / Intestinos / Anti-Inflamatórios Limite: Animals / Humans / Male Idioma: En Revista: Biomaterials Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Finlândia
...